Startup
Every investor coverage indicates participated in a round Samphire Neuroscience raised.
Companies Samphire Neuroscience acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Alex Cook | Founder | Alberts Impact Ventures, Afterwork Ventures portfolio |
Stories naming Samphire Neuroscience. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Alberts' annual review records its venture arm closing its portfolio at 22 companies, topping up six holdings, co-launching a gender-equity drive, and navigating board changes after Sam Mostyn became Governor-General.
Also Startup Daily
Alberts Impact Ventures introduces its new investment associate in a Q&A covering his prior role at an investment platform, his path into impact investing, and portfolio companies in health and climate.
Investor's own year in review: five new portfolio companies, a follow-on into ULUU, the Verve Super exit, the Equity Clear gender-reporting initiative, a first founders' retreat, and a sweep of awards for portfolio companies.
Also OIF Ventures portfolio·Alberts Impact Ventures portfolio·Alberts Impact Ventures portfolio·SmartCompany·Startup Daily·SmartCompany·Women's Agenda·Crunchbase News
Ignition Lane's weekly tech roundup: AirTree raises $700m across three new funds, dozens of Australian startups announce rounds, a wave of acquisitions including Block completing its Afterpay buy, plus Web3 commentary and US market moves.
AfterWork Ventures explains why it invested pre-seed in Samphire Neuroscience, a neurotech startup whose headband eases menstrual symptoms, alongside hardware accelerator HAX, profiling the Oxford-founded team and the women's health opportunity.
Also Startup Daily